tiprankstipranks
Replimune Group Inc (REPL)
NASDAQ:REPL
US Market
REPL
Replimune Group
RESEARCH TOOLSreports
Want to see REPL full AI Analyst Report?

Replimune Group (REPL) Stock News & Sentiment

592 Followers
Replimune Group Lawsuit: Company Asks Court to Dismiss Securities Case Over RP1 FDA Approval Process
Premium
Class Action
Replimune Group Lawsuit: Company Asks Court to Dismiss Securities Case Over RP1 FDA Approval Process
13d ago
REPL
Replimune Group Lawsuit Focuses on FDA Disclosure Issues and Sharp REPL Stock Drop
Premium
Class Action
Replimune Group Lawsuit Focuses on FDA Disclosure Issues and Sharp REPL Stock Drop
19d ago
REPL
Replimune Group Lawsuit Focuses on FDA Disclosure Issues and Sharp REPL Stock Drop
Premium
Class Action
Replimune Group Lawsuit Focuses on FDA Disclosure Issues and Sharp REPL Stock Drop
22d ago
REPL
Replimune Group Lawsuit Alleges Investors Were Misled Before REPL Stock Drop
Premium
Class Action
Replimune Group Lawsuit Alleges Investors Were Misled Before REPL Stock Drop
26d ago
REPL
Replimune Raises $150 Million in Equity Offering
Premium
Company Announcements
Replimune Raises $150 Million in Equity Offering
1M ago
8K
REPL
Replimune Wins FDA Accelerated Approval for TUDRIQEV
Premium
Company Announcements
Replimune Wins FDA Accelerated Approval for TUDRIQEV
1M ago
8K
REPL
These 2 Stocks Just Broke Out — and They Could Go Higher, Say Analysts
Premium
Market News
These 2 Stocks Just Broke Out — and They Could Go Higher, Say Analysts
1M ago
AXTI
REPL
More REPL News >

REPL News on the Web

Replimune Group Lawsuit: Company Asks Court to Dismiss Securities Case Over RP1 FDA Approval Process
TipRanks News
Neutral
HHS plans new FDA deputy commissioner roles for technology and drugs, sources say
CNBC
Bullish
Replimune Group Lawsuit Focuses on FDA Disclosure Issues and Sharp REPL Stock Drop
TipRanks News
Bearish
REPL SWOT Analysis: FDA Approval of TUDRIQEV Marks a Turning Point
GuruFocus News
Bullish
Replimune Group Lawsuit Alleges Investors Were Misled Before REPL Stock Drop
TipRanks News
Bearish
Replimune’s $150 Million Offering Underscores Confidence in Oncolytic Immunotherapy Platform
Market Chameleon
Neutral
These 2 Stocks Just Broke Out — and They Could Go Higher, Say Analysts
TipRanks News
Bullish
‘Blue Sky’ Ahead? J.P. Morgan Picks 2 Stocks to Buy for the Rest of 2026
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average6.75 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is REPL’s Media Buzz Sentiment?
Currently, no data Available
What is REPL’s weekly average amount of articles?
In an average week, 6.75 articles about REPL are published.
    What is REPL’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    HCMHUTCHMED
    GHGuardant Health
    BIIBBiogen
    MODDModular Medical
    SMMTSummit Therapeutics
    Showing the stocks with the most bullish news sentiment over the past week